Amed Valuation
Is 7575 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 7575 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 7575's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 7575's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 7575?
Key metric: As 7575 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 7575's PB Ratio? | |
|---|---|
| PB Ratio | n/a |
| Book | NT$0 |
| Market Cap | NT$1.33b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 7575's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.7x | ||
6543 Perfect Medical Industry | 1.7x | n/a | NT$1.4b |
4735 AViTA | 1.6x | n/a | NT$1.4b |
6649 Taiwan Biomaterial | 2.4x | n/a | NT$1.5b |
3373 Radiant Innovation | 1.1x | n/a | NT$961.0m |
7575 Amed | n/a | n/a | NT$1.3b |
Price-To-Book vs Peers: Insufficient data to calculate 7575's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Book Ratio vs Industry
How does 7575's PB Ratio compare vs other companies in the TW Medical Equipment Industry?
| 0 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Book vs Industry: Insufficient data to calculate 7575's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is 7575's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | n/a |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 7575's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Universal Vision Biotechnology
NT$18.3b
Operates a chain of eye care clinics in Taiwan and China.
3218
NT$215.50
7D
1.9%
1Y
-27.1%
Hi-Clearance
NT$6.2b
Supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan.
1788
NT$138.50
7D
0.4%
1Y
2.6%
Pacific Hospital Supply
NT$6.5b
Manufactures, processes, and sells medical disposable products and equipment in Taiwan.
4126
NT$89.00
7D
-0.3%
1Y
6.0%